MedTrace Logo

Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis

NCT05902078 · Status: RECRUITING · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2024-05-16

No results posted yet for this study

Summary

To investigate the efficacy and safety of eldecalcitol in postmenopausal women with low bone mineral density (BMD) or mild osteoporosis through a randomized, open-label, parallel controlled trial with calcitriol as the control.

Conditions

  • Low Bone Mineral Density
  • Postmenopausal Osteoporosis

Interventions

DRUG

Eldecalcitol capsules

Oral eldecalcitol 0.75μg daily

DRUG

Calcitriol capsules

Oral calcitriol 0.5μg daily

Sponsors & Collaborators

  • Chugai Pharma China Co., Ltd.

    collaborator UNKNOWN

  • Shanghai Jiao Tong University Affiliated Sixth People's Hospital

    lead OTHER

Principal Investigators

  • Zhenlin Zhang · Shanghai Jiao Tong University Affiliated Sixth People's Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-27
Primary Completion
2025-06-30
Completion
2025-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05902078 on ClinicalTrials.gov